Loading stock data…
CLGN
$0.41+0.03 (+7.23%)
Market ClosedLast close May 1
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
CollPlant Biotechnologies Ltd. in the Healthcare sector is trading at $0.41. The stock is currently near its 52-week low of $0.27, remaining 75.7% below its 200-day moving average. Technical signals show neutral RSI of 65 and bullish MACD crossover, explaining why CLGN maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 65) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.41
Potential Upside
5%
Whystock Fair Value$0.43
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company'...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.66M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.94
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-188.93%
Volume
Today's trading volume
29,125
Recent News
When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Turn A Profit?
We feel now is a pretty good time to analyse CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) business as it appears...
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering
CollPlant (CLGN) Biotechnologies announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 1.6M of the company’s ordinary shares at a purchase price of $1.25 per share in a registered direct offering. In addition, in a concurrent private placement, the company will issue unregistered series A warrants to purchase up to 1.6M ordinary shares and unregistered series B warrants to purchase up to 1.6M ordinary shares. The series A warrants will have an exe
Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, although...
One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year
From what we can see, insiders were net buyers in CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) during the past 12...
Discover May 2025's Top Penny Stocks
Over the last 7 days, the U.S. market has risen by 1.2%, contributing to a 12% increase over the past year, with earnings anticipated to grow by 14% annually. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever; these stocks can provide a mix of affordability and growth potential when paired with strong financials. Below, we'll explore three penny stocks that stand out for their financial strength and resilience in today's...